Charles Roux

1.7k total citations
78 papers, 1.2k citations indexed

About

Charles Roux is a scholar working on Surgery, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Charles Roux has authored 78 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Surgery, 15 papers in Hepatology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Charles Roux's work include Cholesterol and Lipid Metabolism (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (12 papers) and Peroxisome Proliferator-Activated Receptors (6 papers). Charles Roux is often cited by papers focused on Cholesterol and Lipid Metabolism (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (12 papers) and Peroxisome Proliferator-Activated Receptors (6 papers). Charles Roux collaborates with scholars based in France, United States and United Kingdom. Charles Roux's co-authors include Claude Wolf, Françoise Chevy, Thierry de Baère, Frédèric Deschamps, Lambros Tselikas, D. Citadelle, Alexandre Delpla, Martine Kolf‐Clauw, Antoine Hakimé and R Dupuis and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Radiology.

In The Last Decade

Charles Roux

71 papers receiving 1.2k citations

Peers

Countries citing papers authored by Charles Roux

Since Specialization

Citations

This map shows the geographic impact of Charles Roux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Roux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Roux more than expected).

Fields of papers citing papers by Charles Roux

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Roux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Roux. The network helps show where Charles Roux may publish in the future.

Co-authorship network of co-authors of Charles Roux

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Roux. A scholar is included among the top collaborators of Charles Roux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Roux. Charles Roux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Overt hepatic encephalopathy after elective and preemptive TIPS: Risk factors and prognosis 2025 ·JHEP Reports ·(unknown), (unknown), Philippe Sultanik, Charles Roux, (unknown), (unknown), (unknown), Nicolas Weiss, (unknown), (unknown), Hélène Larrue, Christophe Bureau, (unknown), (unknown), Dominique Thabut	1
2	Bioresorbable scaffolds in interventional radiology: Current concepts and future direction 2025 ·Diagnostic and Interventional Imaging ·Charles Roux, (unknown), (unknown), (unknown), Jonathan Cortese, (unknown), Fan Sun, Graciela Pavon‐Djavid, Yun Luo, Claire Mangeney, Géraud Forestier, Frédéric Clarençon, Aymeric Rouchaud	0
3	Enhanced therapeutic outcomes with atezolizumab-bevacizumab and SIRT combination compared to SIRT alone in unresectable HCC: A promising approach for improved survival 2024 ·Clinics and Research in Hepatology and Gastroenterology ·(unknown), Charles Roux, M. Soret, (unknown), Mathilde Wagner, (unknown), Charlotte Lussey‐Lepoutre, Dominique Thabut, Claire Goumard, Philippe Maksud, Manon Allaire	7
4	Impact of conventional and biological disease-modifying anti-rheumatic drugs on arterial lesions in Takayasu arteritis 2024 ·Lara D. Veeken ·(unknown), (unknown), Kristell Desseaux, Mathieu Vautier, L. Chiche, Alexandre Le Joncour, Alban Redheuil, Charles Roux, P. Cacoub, Julien Gaudric, Lucie Biard, David Saadoun	0
5	Portal hypertension is associated with poorer outcome and clinical liver decompensation in patients with HCC treated with Atezolizumab-Bevacizumab 2024 ·Digestive and Liver Disease ·Philippe Sultanik, Claudia Campani, (unknown), (unknown), (unknown), Charles Roux, Lorraine Blaise, Mathilde Wagner, Marika Rudler, Jean‐Charles Nault, Dominique Thabut, Manon Allaire	7
6	Non selective beta-blockers prevent PHT-related complications occurrence in HCC patients with esophageal varices treated by TACE 2024 ·Clinics and Research in Hepatology and Gastroenterology ·Manon Allaire, (unknown), (unknown), (unknown), (unknown), Claire Goumard, Olivier Lucidarme, Marika Rudler, Olivier Scatton, Charles Roux, Mathilde Wagner, Dominique Thabut	1
7	Recent advances in Fe-based bioresorbable stents: Materials design and biosafety 2023 ·Bioactive Materials ·(unknown), Charles Roux, Aymeric Rouchaud, Anne Meddahi‐Pellé, Virginie Gueguen, Claire Mangeney, Fan Sun, Graciela Pavon‐Djavid, Yun Luo	25
8	Thermal ablation of ultrasound and non-contrast computed tomography invisible primary and secondary liver tumors: targeting by selective intra-arterial lipiodol injection 2023 ·Diagnostic and Interventional Radiology ·Adrian Kobe, Lambros Tselikas, Frédèric Deschamps, Charles Roux, Alexandre Delpla, (unknown), Antoine Hakimé, Thierry de Baère	2
9	Evaluation of a New CT-Guided Robotic System for Percutaneous Needle Insertion for Thermal Ablation of Liver Tumors: A Prospective Pilot Study 2022 ·CardioVascular and Interventional Radiology ·Thierry de Baère, Charles Roux, Frédèric Deschamps, Lambros Tsélikas, Boris Guiu	38
10	New endpoints in adrenocortical carcinoma studies: a mini review 2022 ·Endocrine ·Matthieu Faron, Livia Lamartina, S. Hescot, Sophie Moog, Frédèric Deschamps, Charles Roux, Rossella Libé, (unknown), Abir Al Ghuzlan, Julien Hadoux, Éric Baudin	1
11	Interventional Radiology for Local Immunotherapy in Oncology 2021 ·Clinical Cancer Research ·Lambros Tselikas, Stéphane Champiat, Rahul A. Sheth, (unknown), Samy Ammari, Frédèric Deschamps, Siham Farhane, Charles Roux, Sandrine Susini, Séverine Mouraud, Alexandre Delpla, (unknown), Caroline Robert, Christophe Massard, Fabrice Barlési, Jean‐Charles Soria, Aurélien Marabelle, Thierry de Baère	26
12	The PEARL Approach for CT-guided Lung Biopsy: Assessment of Complication Rate 2021 ·Radiology ·Arash Najafi, (unknown), (unknown), Alexandre Delpla, Adrian Kobe, (unknown), Charles Roux, Frédèric Deschamps, Thierry de Baère, Lambros Tsélikas	28
13	Image-guided Percutaneous Fixation with Internal Cemented Screws of Impending Femoral Neck Pathologic Fractures in Patients with Metastatic Cancer: Safety, Efficacy, and Durability 2020 ·Radiology ·(unknown), Charles Roux, Lambros Tsélikas, Alexandre Delpla, Steven Yevich, Matthieu Faron, C. Tériitéhau, Antoine Hakimé, (unknown), Thierry de Baère, Frédèric Deschamps	19
14	Lung microwave ablation – an in vivo swine tumor model experiment to evaluate ablation zones 2020 ·International Journal of Hyperthermia ·(unknown), C. Tériitéhau, Julien Adam, Jimmy Kyaw Tun, Charles Roux, Antoine Hakimé, Alexandre Delpla, Frédèric Deschamps, Thierry de Baère, Lambros Tselikas	13
15	Radiofrequency ablation versus surgical resection for the treatment of oligometastatic lung disease 2020 ·Diagnostic and Interventional Imaging ·Lambros Tselikas, Lorenzo Garzelli, Olaf Mercier, A. Aupérin, Lilia Lamrani, Frédèric Deschamps, Steven Yevich, Charles Roux, Sacha Mussot, Alexandre Delpla, (unknown), Antoine Hakimé, C. Tériitéhau, C. Le Péchoux, Pauline Pradère, Caroline Caramella, Benjamin Besse, Élie Fadel, Thierry de Baère	23
16	Lung Ablation – How I Do It 2020 ·Techniques in vascular and interventional radiology ·Arash Najafi, Thierry de Baère, (unknown), (unknown), Charles Roux, Alexandre Delpla, Frédèric Deschamps, Lambros Tselikas	4
17	Both sunitinib and sorafenib are effective treatments for pheochromocytoma in a xenograft model 2014 ·Cancer Letters ·(unknown), Laurent Yon, Charles Roux, Bruno J. Gonzalez, Éric Baudin, Youssef Anouar, Christophe Dubessy	14
18	Absence of ventral cell populations in the developing brain in a rat model of the Smith-Lemli-Opitz syndrome 1999 ·American Journal of Medical Genetics ·(unknown), Martine Kolf‐Clauw, Frédéric Clotman, Charles Roux, Jacques Picard	27
19	Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz and the lethal acrodysgenital syndromes 1996 ·European Journal of Pediatrics ·Valérie Cormier‐Daire, Claude Wolf, Arnold Münnich, M. Le Merrer, A Nivelon, Dominique Bonneau, Hubert Journel, Florence Fellmann, Françoise Chevy, Charles Roux	10
20	Cholesterol Prevents the Teratogenic Action of AY 9944: Importance of the Timing of Cholesterol Supplementation to Rats 1988 ·Journal of Nutrition ·Véronique Barbu, Charles Roux, (unknown), R Dupuis, J. Gardette, (unknown), Cécile Mazière, Élisabeth Éléfant, J. Polonovski	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact